Acrizanib
Acrizanib (LHA510, LHA-510) is a novel potent, selective VEGFR-2 (KDR) inhibitor with IC50 of 17.4 nM in cell-based assays.
Product Specifications
CAS Number
1229453-99-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
445.406
Molecular Formula
C20H18F3N7O2
Notes
Research use only, not for human use.
Receptor
VEGFR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6007827-01 0.05 mg
FABP6 (Intestinal Bile Acid-binding Protein, I-BABP, Intestinal 15kD Protein, I-15P, Ileal Lipid-binding Protein, ILBP, Fatty Acid-binding Protein 6, Gastrotropin, GT, ILBP, ILLBP)
Ask
View Details 
MBS6007827-02 5x 0.05 mg
FABP6 (Intestinal Bile Acid-binding Protein, I-BABP, Intestinal 15kD Protein, I-15P, Ileal Lipid-binding Protein, ILBP, Fatty Acid-binding Protein 6, Gastrotropin, GT, ILBP, ILLBP)
Ask
View Details ![COX17 Mouse Monoclonal Antibody [Clone ID: LBI1C2]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MBS6176800-01 0.1 mL
GCM1 (glial Cells missing Homolog 1 (Drosophila), GCMA, hGCMa) (FITC)
Ask
View Details MBS6176800-02 5x 0.1 mL
GCM1 (glial Cells missing Homolog 1 (Drosophila), GCMA, hGCMa) (FITC)
Ask
View Details MBS1173941-01 0.02 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_1555 (AF_1555)
Ask
View Details